About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiome Research’s group seeks to investigate the role of the microbiota in health and disease. Its secondary objectives include developing molecular as well as bioinformatics tools to characterize the microbiome structure and function, discovering micro-biomarkers for diagnosis and prognosis, investigating how fecal microbiota transplantation could be used as a therapeutic strategy, and evaluating the impact of diet on the gut microbial ecosystem The Microbiome Lab is a multidisciplinary team, composed of molecular biologists, bioinformaticians, and physicians. The group tackles several clinical fields including inflammatory bowel diseases, diabetes, liver diseases, pre-term birth, and critical illness.
PMID: 38098063 Journal: Microbiome Year: 2023 Reference: Microbiome. 2023 Dec 14;11(1):275. doi: 10.1186/s40168-023-01693-w. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Canalda-Baltrons, Aleix; Card-Gowers, Joshua; d'Enfert, Christophe; Graff, Hannah; Guzek, John; Jepsen, Peter; Lazarus, Jeffrey V; Manichanh, Chaysavanh; Martin, Alexander et al. DOI: 10.1186/s40168-023-01693-w
PMID: 38108358 Journal: Journal of neuromuscular diseases Year: 2023 Reference: J Neuromuscul Dis. 2023 Dec 15. doi: 10.3233/JND-230027. Impact factor: Publication type: Paper in international publication Authors: Bhai, Salman; Bloemen, Bart; Canalda-Baltrons, Aleix; Coppers, Jacqueline; Cup, Edith; d'Enfert, Christophe; Groothuis, Jan T; Karazi, Walaa; Lokken, Nicoline; Maas, Daphne et al. DOI: 10.3233/JND-230027
The study also linked improved microbiota diversity to better liver function.
This work sets the basis for future research aimed at a deeper understanding of the microbiota and the effect of nutrition.
These are the results of a study published in Nature Communications and led by the Vall d'Hebron Research Institute (VHIR), the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida).
Check the current rates of the services offered by the Microbiome Research group
We are looking for approximately 1,000 volunteers who will have to answer a very simple questionnaire about their eating habits and provide a stool sample, 3 times over the course of a year.
